Found: 21
Select item for more details and to access through your institution.
Dramatic response to alectinib in inflammatory myofibroblastic tumor with anaplastic lymphoma kinase fusion gene.
- Published in:
- Japanese Journal of Clinical Oncology, 2017, v. 47, n. 12, p. 1189, doi. 10.1093/jjco/hyx133
- By:
- Publication type:
- Article
Association Between the Efficacy of Pembrolizumab and Low STK11/LKB1 Expression in High-PD-L1-expressing Non-small-cell Lung Cancer.
- Published in:
- In Vivo, 2020, v. 34, n. 5, p. 2997, doi. 10.21873/invivo.12131
- By:
- Publication type:
- Article
Characteristics of central nervous system progression in non‐small cell lung cancer treated with crizotinib or alectinib.
- Published in:
- Cancer Reports, 2021, v. 4, n. 6, p. 1, doi. 10.1002/cnr2.1414
- By:
- Publication type:
- Article
Soluble interleukin-2 receptor as a predictive biomarker for poor efficacy of combination treatment with anti-PD-1/PD-L1 antibodies and chemotherapy in non-small cell lung cancer patients.
- Published in:
- Investigational New Drugs, 2023, v. 41, n. 3, p. 411, doi. 10.1007/s10637-023-01358-3
- By:
- Publication type:
- Article
EGFR-TKI re-administration after osimertinib failure in T790M mutation loss cases with re-biopsy.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 6, p. 1342, doi. 10.1007/s10637-022-01301-y
- By:
- Publication type:
- Article
Phase II study of the combination of S-1 with bevacizumab for patients with previously treated advanced non-squamous non-small-cell lung cancer.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 3, p. 507, doi. 10.1007/s10147-020-01822-7
- By:
- Publication type:
- Article
Characterization of Computed Tomography Imaging of Rearranged During Transfection-rearranged Lung Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Second-line immunosuppressant administration for steroid-refractory immune-related adverse events in patients with lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3765, doi. 10.1007/s00262-023-03528-x
- By:
- Publication type:
- Article
Distinction of ALK fusion gene- and EGFR mutation-positive lung cancer with tumor markers.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 10, p. 788, doi. 10.1111/1759-7714.15268
- By:
- Publication type:
- Article
Efficacy of osimertinib in patients with EGFR‐mutation positive non‐small cell lung cancer with malignant pleural effusion.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 5, p. 402, doi. 10.1111/1759-7714.15210
- By:
- Publication type:
- Article
Clinical characteristics of patients with KRAS mutation detected by liquid biopsy.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 33, p. 3317, doi. 10.1111/1759-7714.15123
- By:
- Publication type:
- Article
Clinical characteristics of patients with KRAS mutation detected by liquid biopsy.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 31, p. 3317, doi. 10.1111/1759-7714.15123
- By:
- Publication type:
- Article
Clinical influence of switching companion diagnostic tests for EGFR‐TKs from Therascreen to Cobas v2.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 6, p. 906, doi. 10.1111/1759-7714.13797
- By:
- Publication type:
- Article
Feasibility of next‐generation sequencing test for patients with advanced NSCLC in clinical practice.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 4, p. 504, doi. 10.1111/1759-7714.13786
- By:
- Publication type:
- Article
Poor efficacy of anti‐programmed cell death‐1/ligand 1 monotherapy for non‐small cell lung cancer patients with active brain metastases.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 9, p. 2465, doi. 10.1111/1759-7714.13557
- By:
- Publication type:
- Article
Subsequent treatment for locally advanced non-small-cell lung cancer that progressed after definitive chemoradiotherapy and consolidation therapy with durvalumab: a multicenter retrospective analysis (TOPGAN 2021-02).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 1, p. 29, doi. 10.1007/s00280-023-04547-2
- By:
- Publication type:
- Article
Efficacy of EGFR tyrosine kinase inhibitors in patients having EGFR-activating mutations with or without BIM polymorphisms.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Microsecond-timescale MD simulation of EGFR minor mutation predicts the structural flexibility of EGFR kinase core that reflects EGFR inhibitor sensitivity.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00170-7
- By:
- Publication type:
- Article
Susceptibilities of medaka (Oryzias latipes) cell linesto a betanodavirus.
- Published in:
- Virology Journal, 2010, v. 7, p. 150, doi. 10.1186/1743-422X-7-150
- By:
- Publication type:
- Article
Monitoring epidermal growth factor receptor C797S mutation in Japanese non–small cell lung cancer patients with serial cell‐free DNA evaluation using digital droplet PCR.
- Published in:
- Cancer Science, 2021, v. 112, n. 6, p. 2371, doi. 10.1111/cas.14879
- By:
- Publication type:
- Article
Barcode sequencing identifies resistant mechanisms to epidermal growth factor receptor inhibitors in circulating tumor DNA of lung cancer patients.
- Published in:
- Cancer Science, 2019, v. 110, n. 10, p. 3350, doi. 10.1111/cas.14153
- By:
- Publication type:
- Article